Sitagliptin treatment of rotenone-induced Parkinson’s disease albino rats showed positive effects in preventing PD progression because of its “antiapoptotic, neurogenic, neurotrophic and anti-inflammatory activities” [147] but increased tau phosphorylation in T2D rats and primary neuron cultures [148]. This evidence concerns the gene MAPT and Parkinson disease.